VTechWorks staff will be away for the Thanksgiving holiday beginning at noon on Wednesday, November 27, through Friday, November 29. We will resume normal operations on Monday, December 2. Thank you for your patience.
 

Proteomic Map of ER+ Breast Cancer Cell Cycle

Simple item page
dc.contributor.authorTenga, Milagros Janneten
dc.contributor.committeechairLazar, Iuliana M.en
dc.contributor.committeememberSible, Jill C.en
dc.contributor.committeememberHelm, Richard F.en
dc.contributor.committeememberWalker, Richard A.en
dc.contributor.departmentBiologyen
dc.date.accessioned2017-04-06T15:42:22Zen
dc.date.adate2012-06-07en
dc.date.available2017-04-06T15:42:22Zen
dc.date.issued2012-05-01en
dc.date.rdate2016-10-18en
dc.date.sdate2012-05-06en
dc.description.abstractCancer is characterized by a deregulation of the cell cycle resulting in abnormal proliferation of cells that can bypass tightly regulated molecular checkpoints. Breast cancer is the most common cancer diagnosed in women, ~70% of cases displaying an estrogen receptor positive (ER+) phenotype. The aim of the present work was to generate a comprehensive overview of the biological mechanisms, molecular pathways and specific proteins involved in cell cycle progression in ER+ breast cancer cells. We focused on the G1-to-S phase transition of the cell cycle because major differences in cell proliferation mechanisms between normal and cancerous cells are observed at this point. We developed a large-scale proteomics strategy to enable the comparison of MCF-7 ER+ (cancer) and MCF-10A (non-tumorigenic) epithelial breast cells. Samples were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) followed by a label-free quantitation approach, i.e., spectral counting, for differential protein expression analysis. The study was divided into three distinct parts: 1) qualitative profiling of MCF-7 cells arrested in the G1-phase and released into the S-phase of the cell cycle, 2) differential expression profiling of MCF-7 cells in G1 and S, and 3) differential expression profiling of the G1-phases of MCF-7 and MCF-10A cells. The qualitative evaluation of MCF-7 proteomic data resulted in the identification of >2700 proteins (p-score<0.001). A large number of these proteins were involved in cell cycle relevant processes, being representative of all hallmarks of cancer. Differential expression analysis of the MCF-7 G1 and S-phases resulted in the identification of >250 proteins with roles in DNA repair, transcription, translation, chromatin maintenance and signaling. The MCF-7/MCF-10 comparison revealed that major cellular processes that require DNA access, such as the ones identified in the MCF-7 analysis, are up-regulated in the nucleus of MCF-7 cells during starvation, possibly allowing these cancerous cells to bypass the restriction point. Several proliferative and anti-proliferative markers were identified in both MCF-7 and MCF-10A cells.en
dc.description.degreePh. D.en
dc.identifier.otheretd-05062012-035226en
dc.identifier.sourceurlhttp://scholar.lib.vt.edu/theses/available/etd-05062012-035226/en
dc.identifier.urihttp://hdl.handle.net/10919/77066en
dc.language.isoen_USen
dc.publisherVirginia Techen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectbreast canceren
dc.subjectmass spectrometryen
dc.subjectcell cycleen
dc.subjectproteomicsen
dc.titleProteomic Map of ER+ Breast Cancer Cell Cycleen
dc.typeDissertationen
dc.type.dcmitypeTexten
thesis.degree.disciplineBiologyen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.leveldoctoralen
thesis.degree.namePh. D.en

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
etd-05062012-035226_Tenga_MJ_D_2012.pdf
Size:
3.83 MB
Format:
Adobe Portable Document Format
Download

Collections

Doctoral Dissertations